Jaw Cysts: Clinical Trials

2 completed, 2 not yet recruiting, 2 terminated, 1 withdrawn. 7 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	7	Completed 2, Not yet recruiting 2, Terminated 2, Withdrawn 1
Phase 2	1	Withdrawn 1

Follow Jaw Cysts: new trials by email Literature Review of Jaw Cysts trials Research Report on Jaw Cysts

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Low-Intensity Pulsed Ultrasound as an Adjunctive Therapy for Bone Regeneration Following Jaw Cyst Enucleation Low-Intensity Pulsed Ultrasound - Jaw Cysts, Curettage	Phase 3	Not yet recruiting	Sadam Elayah	29	2025-10-22	2025-10-07
Using of Bone Marrow Stem Cell Concentrate with Platelet Rich Fibrin and Bone Graft in Bone Reconstruction of Upper Jaw Bony Cystic Defects, Comparing with Platelet Rich Fibrin with Bone Graft Bone marrow stem cells concentrate , platelet rich fibrin , bone graft, platelet rich fibrin and bone graft - Maxillary Cyst	Phase 3	Not yet recruiting	Cairo University	22	2024-10-26	2024-10-29
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome Patidegib Topical Gel, Patidegib Topical Gel with no active patidegib - Gorlin Syndrome	Phase 3	Completed	Sol-Gel Technologies, Ltd.	113	2024-03-17	2026-09-18
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome) Patidegib Topical Gel, 2% - Basal Cell Nevus Syndrome	Phase 3	Terminated	Sol-Gel Technologies, Ltd.	108	2020-06-03	2024-09-24
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle - Basal Cell Nevus Syndrome	Phase 3	Completed	Sol-Gel Technologies, Ltd.	174	2019-02-19	2024-07-03
Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. verteporfin PDT - Basal Cell Carcinoma, Nevoid Basal Cell Carcinoma Syndrome	Phase 3	Terminated	QLT Inc.			2011-03-16
Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) LDE225B, Vehicle - Basal Cell Carcinoma	Phase 2 / Phase 3	Withdrawn	Novartis Pharmaceuticals			2017-05-05

Narrower conditions

Basal Cell Nevus Syndrome (5)  ·  Carcinoma, Basal Cell (4)  ·  Basal cell carcinoma, multiple (1)

Broader conditions

Bone Cysts (7)  ·  Cysts (7)  ·  Jaw Diseases (7)  ·  Musculoskeletal Diseases (7)  ·  Neoplasms (7)  ·  Stomatognathic Diseases (7)  ·  Abnormalities, Multiple (5)  ·  Bone Diseases (5)  ·  Bone Diseases, Developmental (5)  ·  Carcinoma (5)  ·  Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Neoplasms by Histologic Type (5)

Interventions

Bone Transplantation (1)  ·  IPI-926 (1)

Sponsors

Sol-Gel Technologies, Ltd. (3)  ·  Cairo University (1)  ·  Novartis Pharmaceuticals (1)  ·  QLT Inc. (1)  ·  Sadam Elayah (1)

Countries

Germany (4)  ·  Italy (4)  ·  Spain (4)  ·  United Kingdom (4)  ·  Belgium (3)  ·  France (3)  ·  Netherlands (3)  ·  United States (3)  ·  Canada (2)  ·  Denmark (2)  ·  Czechia (1)  ·  Finland (1)  ·  Greece (1)  ·  Switzerland (1)

Top investigators

Herma Neyndorff (1)

Results publications

PMID 11873920, PMID 28953676, PMID 32145206

NIH funding

2023 (1)